Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Savale, Laurent ^a,b   Tu, Ly ^a   Rideau, Dominique ^a   Izziki, Mohamed ^a   Maitre, Bernard ^a,b   Adnot, Serge ^a,b   Eddahibi, Saadia ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; MESSENGER RNA; IL6 PROTEIN, HUMAN; INTERLEUKIN 6 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY MUSCLE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG BLOOD VESSEL; LUNG ENDOTHELIUM; MOUSE; NONHUMAN; PNEUMONIA; PULMONARY ARTERY; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; ANIMAL; ANOXIA; BLOOD PRESSURE; C57BL MOUSE; CELL CULTURE; CELL MOTION; DISEASE MODEL; GENETICS; IMMUNOLOGY; LUNG; MACROPHAGE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; TIME; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANOXIA; BLOOD PRESSURE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINE RECEPTOR GP130; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; INTERLEUKIN-6; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; PNEUMONIA; PULMONARY ARTERY; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; TIME FACTORS;

EID: 61549104663     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-6     Document Type: Article

References (37)

1. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003, 22(2):358-363. 10.1183/09031936.03.00038903, 12952274.
2. Tuder RM, Voelkel NF. Pulmonary hypertension and inflammation. J Lab Clin Med 1998, 132(1):16-24. 10.1016/S0022-2143(98)90020-8, 9665367.
3. Peinado VI, Barbera JA, Abate P, Ramirez J, Roca J, Santos S, Rodriguez-Roisin R. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159(5 Pt 1):1605-1611.
4. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995, 151(5):1628-1631.
5. Balabanian K, Foussat A, Dorfmuller P, Durand-Gasselin I, Capel F, Bouchet-Delbos L, Portier A, Marfaing-Koka A, Krzysiek R, Rimaniol AC, et al. CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 2002, 165(10):1419-1425. 10.1164/rccm.2106007, 12016106.
6. Schober A, Zernecke A. Chemokines in vascular remodeling. Thromb Haemost 2007, 97(5):730-737.
7. Marasini B, Cossutta R, Selmi C, Pozzi MR, Gardinali M, Massarotti M, Erario M, Battaglioli L, Biondi ML. Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension. Clin Dev Immunol 2005, 12(4):275-279. 2270742, 16584113, 10.1080/17402520500303297.
8. Dorfmuller P, Zarka V, Durand-Gasselin I, Monti G, Balabanian K, Garcia G, Capron F, Coulomb-Lhermine A, Marfaing-Koka A, Simonneau G, et al. Chemokine RANTES in severe pulmonary arterial hypertension. Am J Respir Crit Care Med 2002, 165(4):534-539.
9. Itoh T, Nagaya N, Ishibashi-Ueda H, Kyotani S, Oya H, Sakamaki F, Kimura H, Nakanishi N. Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension. Respirology 2006, 11(2):158-163. 10.1111/j.1440-1843.2006.00821.x, 16548900.
10. Sanchez O, Marcos E, Perros F, Fadel E, Tu L, Humbert M, Dartevelle P, Simonneau G, Adnot S, Eddahibi S. Role of Endothelium-Derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2007,
11. Eddahibi S, Chaouat A, Tu L, Chouaid C, Weitzenblum E, Housset B, Maitre B, Adnot S. Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006, 3(6):475-476. 10.1513/pats.200603-038MS, 16921112.
12. Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 2006, 8(Suppl 2):S2. 10.1186/ar1916, 16899106.
13. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86(2):515-581. 10.1152/physrev.00024.2005, 16601268.
14. Lesprit P, Godeau B, Authier FJ, Soubrier M, Zuber M, Larroche C, Viard JP, Wechsler B, Gherardi R. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. Am J Respir Crit Care Med 1998, 157(3 Pt 1):907-911.
15. Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F, De Pita O, Puddu P, Paganelli R, Russo G. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 2004, 138(3):540-546. 1809238, 15544634, 10.1111/j.1365-2249.2004.02642.x.
16. Yoshio T, Masuyama JI, Kohda N, Hirata D, Sato H, Iwamoto M, Mimori A, Takeda A, Minota S, Kano S. Association of interleukin 6 release from endothelial cells and pulmonary hypertension in SLE. J Rheumatol 1997, 24(3):489-495.
17. Hoeper MM, Welte T. Systemic inflammation, COPD, and pulmonary hypertension. Chest 2007, 131(2):634-635. 10.1378/chest.06-2207, 17296674.
18. Wang GS, Qian GS, Mao BL, Cai WQ, Chen WZ, Chen Y. [Changes of interleukin-6 and Janus kinases in rats with hypoxic pulmonary hypertension]. Zhonghua Jie He He Hu Xi Za Zhi 2003, 26(11):664-667.
19. Yan SF, Ogawa S, Stern DM, Pinsky DJ. Hypoxia-induced modulation of endothelial cell properties: regulation of barrier function and expression of interleukin-6. Kidney Int 1997, 51(2):419-425. 10.1038/ki.1997.56, 9027716.
20. Yan SF, Tritto I, Pinsky D, Liao H, Huang J, Fuller G, Brett J, May L, Stern D. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem 1995, 270(19):11463-11471. 10.1074/jbc.270.19.11463, 7744784.
21. Golembeski SM, West J, Tada Y, Fagan KA. Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice. Chest 2005, 128(6 Suppl):572S-573S. 10.1378/chest.128.6_suppl.572S-a, 16373831.
22. Miyata M, Sakuma F, Yoshimura A, Ishikawa H, Nishimaki T, Kasukawa R. Pulmonary hypertension in rats. 2. Role of interleukin-6. Int Arch Allergy Immunol 1995, 108(3):287-291.
23. Miyata M, Ito M, Sasajima T, Ohira H, Kasukawa R. Effect of a serotonin receptor antagonist on interleukin-6-induced pulmonary hypertension in rats. Chest 2001, 119(2):554-561. 10.1378/chest.119.2.554, 11171737.
24. Steiner MKSO, Kolliputi N, Mark EJ, Hales CA, Waxman AB. Interleukin-6 Overexpression Induces Pulmonary Hypertension. Circ Res 2008,
25. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994, 368(6469):339-342. 10.1038/368339a0, 8127368.
26. Adnot S, Raffestin B, Eddahibi S, Braquet P, Chabrier PE. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 1991, 87(1):155-162. 295014, 1985092, 10.1172/JCI114965.
27. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001, 108(8):1141-1150. 209526, 11602621.
28. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981, 11(10):805-815. 10.1002/eji.1830111013, 7308288.
29. Hernanz R, Briones AM, Alonso MJ, Vila E, Salaices M. Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteries. Am J Physiol Heart Circ Physiol 2004, 287(1):H225-234. 10.1152/ajpheart.00548.2003, 15001439.
30. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997, 6(3):315-325. 10.1016/S1074-7613(00)80334-9, 9075932.
31. Ulich TR, Yin S, Guo K, Yi ES, Remick D, del Castillo J. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol 1991, 138(5):1097-1101. 1886022, 2024703.
32. Aderka D, Le JM, Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 1989, 143(11):3517-3523.
33. Schieffer B, Selle T, Hilfiker A, Hilfiker-Kleiner D, Grote K, Tietge UJ, Trautwein C, Luchtefeld M, Schmittkamp C, Heeneman S, et al. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 2004, 110(22):3493-3500. 10.1161/01.CIR.0000148135.08582.97, 15557373.
34. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, Kourembanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA 2001, 98(15):8798-8803. 37515, 11447290, 10.1073/pnas.161272598.
35. Wang Z, Newman WH. Smooth muscle cell migration stimulated by interleukin 6 is associated with cytoskeletal reorganization. J Surg Res 2003, 111(2):261-266. 10.1016/S0022-4804(03)00087-8, 12850472.
36. Maggiorini M, Brunner-La Rocca HP, Peth S, Fischler M, Bohm T, Bernheim A, Kiencke S, Bloch KE, Dehnert C, Naeije R, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006, 145(7):497-506.
37. Ali MH, Schlidt SA, Chandel NS, Hynes KL, Schumacker PT, Gewertz BL. Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol 1999, 277(5 Pt 1):L1057-1065.